This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Thomas Valerius, MD
Professor, Faculty of Medicine at University Hospital Schleswig-Holstein


Thomas Valerius studied medicine at the University of Erlangen-Nürnberg, Germany. After his training in internal medicine, he specialized in hematology/oncology and rheumatology. Since May 2003, he has been working at the University in Kiel, Germany, where he currently is assistant professor at the Section for Stem Cell Transplantation and Immunotherapy. His main scientific interests have been effector functions of monoclonal antibodies in tumor therapy with recent focus on EGFR and CD20 as target antigens, and IgA as an alternative antibody isotype.

Agenda Sessions

  • Glutaminyl Cyclase (QC) Inhibition Improves Myeloid Effector Cell Recruitment for Antibody-mediated Tumor Immunotherapy by Interfering with CD47/SIRPa Interactions